Materiality
72
regulatory
Source
External coverage
Decided
2026-06-14
Sonoma Pharmaceuticals said on October 7, 2025 that it registered its manufacturing facility and listed a Microcyn-based facial spray under FDA MoCRA, which expands its ability to commercialize cosmetic products in the U.S.; the read-through is modestly positive for SNOA, though the item is company-sourced and is a regulatory/commercialization step rather than an FDA product approval.